IP Library Granted Patent US 8,361,754
Granted Patent B2
US 8,361,754 · App. 12/568,364 · Granted Jan 29, 2013

Recombinant reverse transcriptases

Inventors: Liangjing Chen (Austin, TX); Robert A. Setterquist (Austin, TX); Gary Latham (Austin, TX)
Assignee: Applied Biosystems, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,754
App. No.
12/568,364
Granted
Jan 29, 2013
Kind
B2
Abstract

The present invention relates to a gene that encodes a hyperactive reverse transcriptase having DNA polymerase activity and substantially reduced RNase H activity, vectors containing the gene and host cells transformed with the invention. The present invention also includes a method of producing the hyperactive reverse transcriptase, producing cDNA from mRNA using the reverse transcriptase of the invention, kits and assay templates made using the hyperactive reverse transcriptase.

Claims (10)

1. A method for RNA amplification comprising the steps of:

reverse transcribing an RNA template into a single-stranded cDNA with an isolated reverse transcriptase comprising SEQ ID NO: 2 in the presence of an oligonucleotide comprising a transcriptional promoter and a primer;

purifying the single-stranded cDNA; and

generating amplified RNA (aRNA) using an RNA polymerase.

2. The method according to claim 1 , wherein the amplified RNA is isolated.

3. A method for RNA amplification comprising the steps of:

reverse transcribing an RNA template into a single-stranded cDNA with an isolated reverse transcriptase comprising SEQ ID NO: 2 in the presence of an oligonucleotide comprising a transcriptional promoter and a primer;

converting the single-stranded cDNA into double-stranded cDNA using a DNA polymerase; and

generating amplified RNA (aRNA) using an RNA polymerase.

4. The method according to claim 3 , wherein the amplified RNA is isolated.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2013
From: CHEN, LIANGJING; SETTERQUIST, ROBERT A.; LATHAM, GARY J.
To: AMBION, INC.
Reel/Frame 029756/0804 →
MERGER Recorded Feb 5, 2013
From: AMBION, INC.
To: APPLERA CORPORATION
Reel/Frame 029756/0898 →
MERGER Recorded Feb 5, 2013
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 029756/0939 →
MERGER Recorded Feb 5, 2013
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 029757/0001 →
MERGER Recorded Feb 5, 2013
From: ATOM ACQUISITION, LLC AND APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 029757/0050 →
Continuity (2)
Continuation 10827498 · Apr 19, 2004
Related Publication 20100203597A1 · Aug 12, 2010